All Type of News
Elderly Patients over 65 Years Take Six Prescription Medications on Average
The domestic elderly outpatients aged over 65 years old are taking multiple medications at the same time, and the average number is nearly six medications per each elderly outpatient, according to a recently published...
Government Pays Over 200 Billion Won for Medication Guidance by Retail Pharmacies
According to a recent statistical analysis conducted by Rep. Kim Chun-jin of the Uri Party on the historical National Health Insurance (NHI) pharmacy care related spending, the medication guidance provisions represent...
SK Launches Anticoagulant Agent in Domestic Market
SK Chemical and SK Pharma announced an official launching of Futhan inj. (active ingredient: nafamostat mesilate), a potent protease inhibitor originally developed by Torii Pharmaceutical of Japan, in the domestic mar...
Pfizer Korea Provides Increased Understanding Towards Lower Urinary Tract Symptom
Pfizer Korea recently held the Year 2005 LUTS (Lower Urinary Tract Symptom) Forum addressed to over 80 urology specialists from the nation's major general hospitals, in an effort to provide an in-depth understanding t...
Government Identifies Neurodegenerative Disorder Treatment as Key Investment Initiative
Among the list of ten strategic investment initiatives identified by the government, based on their potential market commercialization and profitability assessments, the development of novel treatments for degenerativ...
Total National Pension Payout Determined at 2.9 Trillion Won for Last Year
The National Pension Corporation (NPC) has released the actual Year 2004 pension fund activity details, where the total number of beneficiaries was estimated over 1.53 million people receiving the payout total of 2.9 ...
KFDA Seeks Increased Cooperation Towards Providing Current Unit Packaging Details
In order to realize an efficient enforcement of the pharmaceutical small-unit packaging requirement, which is still under review, the Korea Food and Drug Administration (KFDA) recently announced of its directive on th...
Nicotine Replacement Products Now Available at Public Health Centers Nationwide
The recent price hike of the retail cigarette prices, along with the continuous anti-smoking policy and related campaign efforts exerted by the government, are giving new market opportunities for the pharmaceutical ma...
Shinpoong Makes Exclusive Licensing Agreement for Tesmilifene
Shinpoong Pharmaceutical Co. Ltd. announced last week that it made an exclusive domestic licensing agreement with YM BioSciences Inc.'s tesmilifene, a novel anticancer agent currently undergoing a multinational phase ...
InBioNET Submits Market Registration for Human Recombinant Interleukin-2
Upon completion of the domestic phase II clinical trial of interleukin-2 (product name: Geneleukin), a biopharmaceutical anticancer agent, InBioNET Inc. announced last week that it has submitted a market registration ...
